<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">COVID-19 disease has caused millions of morbidities and hundred of thousands of mortalities worldwide (Walker, 2020). The clinical manifestations of COVID-19 are characterized by fever, cough, dyspnea, and bilateral infiltrates on chest imaging [
 <xref rid="bib0130" ref-type="bibr">26</xref>]. After infection, the majority of individuals show moderate symptoms whereas approximately, 20% of the infected patients show severe illness of respiratory failure, septic shock [
 <xref rid="bib0130" ref-type="bibr">26</xref>], gastrointestinal complications [
 <xref rid="bib0130" ref-type="bibr">26</xref>,
 <xref rid="bib0135" ref-type="bibr">27</xref>], myalgias, lymphopenia, and parenchymal lung abnormalities [
 <xref rid="bib0010" ref-type="bibr">2</xref>]. The severity of symptoms and death causing ability of the virus are highly dependent on underlying diseases such as cancer, hypertension, and cardiopulmonary diseases [
 <xref rid="bib0015" ref-type="bibr">3</xref>,
 <xref rid="bib0130" ref-type="bibr">26</xref>]. The infection has been reported to cause high mortalities in older people [
 <xref rid="bib0140" ref-type="bibr">28</xref>] and individuals with blood group A [
 <xref rid="bib0145" ref-type="bibr">29</xref>]. Moreover, pregnant women with confirmed COVID-19 pneumonia can face adverse pregnancy and neonatal impacts [
 <xref rid="bib0150" ref-type="bibr">30</xref>]. The individuals at higher risk of developing severe disease after contracting the infection should be give the priority for treatment and providing the mangeemtn and health servicesConsidering the importance of COVID-19 in the aspects of the asymptomatic spread of the virus and adverse health impacts, it is deemed necessary to investigate the factors associated with the rate of infectiousness and severity of symptoms.
</p>
